Advancing the Understanding and Management of Irritable Bowel Syndrome
Irritable Bowel Syndrome (IBS) is a highly prevalent gastrointestinal disorder that continues to pose significant clinical and research challenges worldwide. Characterized by chronic abdominal discomfort, altered bowel habits, and bloating, IBS not only affects physical health but also has a considerable impact on patients’ quality of life. Its multifactorial etiology—encompassing gut microbiota imbalance, visceral hypersensitivity, immune modulation, and disruptions in the gut-brain axis—necessitates a comprehensive and multidisciplinary approach to management. The 16th World Probiotics, Nutrition & Gut Health Conference and Exhibition , scheduled for December 10–11, 2026, in Kuala Lumpur, Malaysia , will feature Track 19: Irritable Bowel Syndrome , dedicated to addressing the latest scientific and clinical developments in this field. Scientific Perspectives on IBS Recent advancements have redefined IBS as a disorder influenced by complex biological and environmental interac...